Streetbeat News

Stock Prices

IPW

iPower shares surged following the announcement of their Q3 financial results, which exceeded market expectations.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 9:29 pm

PXLW

Pixelworks shares are trading lower following the company's announcement of weaker than expected guidance for Q2.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 9:28 pm

WKHS

Workhorse Group Inc. (NASDAQ:WKHS) stockholders approved a proposal for a reverse stock split of outstanding shares by a ratio between 1-for-10 and 1-for-20, to be executed before August 30, 2024. This move aims to comply with Nasdaq Listing Rules. Additionally, stockholders voted on the re-election of board members and the issuance of shares underlying convertible notes and warrants.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 9:25 pm

HTCR

Heartcore Enterprises reported a Q1 2024 EPS of $(0.06), a decrease from the estimated $0.10, and a revenue of $5.046M, down from $8.734M year-over-year.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 9:24 pm

DPRO

Draganfly shares surged following the announcement of improved year-over-year Q1 EPS results.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 9:22 pm

DPRO

Draganfly reported a Q1 EPS of $(0.02), an improvement from $(0.15) YoY, but sales decreased to $986.46K from $1.19M YoY.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 9:22 pm

HLF

LFVN

OLPX

SKIN

Herbalife (NYSE:HLF) reported Q1 earnings, beating estimates with an EPS of $0.49 against the expected $0.34 and a revenue increase of $12.00 million year-over-year. The company's stock price rose 10.14% following the announcement. Competitors Olaplex Hldgs, Beauty Health, and Lifevantage also reported earnings, with varied performance and stock price reactions. Herbalife's earnings outperformance contrasts with its previous quarter's miss and subsequent share price drop.

Portfolio Pulse from Benzinga Insights

May 14, 2024 | 9:21 pm

PXLW

Pixelworks anticipates Q2 total revenue of $8M-$9M, significantly below the estimated $16.5M, with an adjusted EPS loss of $(0.16)-$(0.13), worse than the estimated $(0.07). The company attributes the shortfall to near-term headwinds in its mobile business but expects a return to sequential growth in H2. The anticipated non-GAAP gross profit margin is between 50% and 52%.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 9:18 pm

GENK

GEN Restaurant Group's shares surged following the announcement of their Q1 financial results, which exceeded market expectations.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 9:11 pm

ARQT

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) reported Q1 earnings of 32 cents per share, surpassing the expected losses of 73 cents. Sales reached $49.57 million, exceeding estimates by 237.66% and marking a 1,680% increase from the previous year. The company highlighted strong sales from its ZORYVE franchise, with significant growth in both its cream and foam products for skin conditions. CEO Frank Watanabe emphasized the successful launch and physician adoption of ZORYVE, anticipating a transformative year ahead with a PDUFA date set for July 7th for ZORYVE cream as a potential atopic dermatitis treatment. Following the announcement, ARQT shares surged 15.01% in after-hours trading.

Portfolio Pulse from Erica Kollmann

May 14, 2024 | 9:11 pm